Evaluation of Antibiotic Use in Pneumonia Patients with Gyssens Method
DOI:
https://doi.org/10.30595/pharmacy.v22i1.17565Keywords:
Antibiotic evaluation, Gyssens method, PneumoniaAbstract
Pneumonia has become a disease that threatens human health and life. A bacterial infection can cause pneumonia, making antibiotics the appropriate choice of therapy. Antibiotics must be used appropriately to avoid the development of resistance. This study qualitatively evaluates the use of antibiotics in pneumonia patients. This cross-sectional observational study utilised the medical records of patients from Dumai City General Hospital retrospectively. Evaluation of the use of antibiotics qualitatively using the Gyssens flow chart. All medical record data of pneumonia patients hospitalised in January–December 2021 became the study population. The inclusion criteria were complete medical records of pneumonia patients aged 18-72 years who received antibiotic prescriptions. Patients who died were excluded from the study. This study involved 57 samples that met the inclusion criteria. Qualitatively, antibiotic use fell into the following categories: Category 0 (82.4%), Category II (10.5%), Category III (1.8%), Category IV C (3.5%), and Category IV A (1.8%).
References
Anggraini W, Candra TM, Maimunah S, Sugihantoro H. 2020. Evaluasi kualitatif penggunaan antibiotik pada pasien infeksi saluran kemih dengan Metode Gyssens, Jurnal Kesehatan dan Kedokteran, 2(2), 1-8.
Anggraini, W. 2021. Evaluasi kualitatif penggunaan antibiotik pada pasien pneumonia RS “X” di Malang, Jurnal Kesehatan dan Kedokteran, 3(1), 9-21.
Bestari MP, Karuniawati K. 2017. Evaluasi rasionalitas dan efektifitas penggunaan antibiotik pada pasien pneumonia pediatrik di Instalasi Rawat Inap Rumah Sakit Pusat Jawa Tengah, Jurnal Farmasi Indonesia. 14(02).
Cilloniz C, Loeches I, Vidal CG, Jose AS, Torres A. 2016. Microbial etiology of pneumonia: Epidemiology, diagnosis and resistance patterns, International Journal of Molecular Sciences, 17(12), 1-2.
Elfidasari D, Noriko N, Mirasaraswati A, Feroza A, Canadianti SF. 2013. Deteksi bakteri klebsiella pneumonia pada beberapa jenis rokok konsumsi Masyarakat, Jurnal Al-Azhar Indonesia Seri Sains Dan Teknologi, 2(1), 41-47.
Farida Y, Ayu T, Deasy NW. 2017. Studi penggunaan antibiotik pada pasien pneumonia di rumah sakit rujukan daerah di Surakarta, Journal of Pharmaceutical Science and Clinical Research, 2(1).
Ganaie FA, Govindan V, Kumar KLR. 2015. Standardisation and evaluation of a quantitative multiplex real-time PCR assay for rapid identification of Streptococcus pneumonia, Pneumonia, 6, 57-66.
Gyssens IC. 2005. Audit for Monitoring the Quality of Antimicrobial Prescription. In: Gould IVM (Editor), Antibiotic Policies: Theory and practice. New York, Kluwer Academic Publishers.
Hardiana I, Laksmitawati DR, Ramadaniati HU, Sutarno. 2021. Evaluasi penggunaan antibiotika pada pasien pneumonia komunitas di Instalansi Rawat Inap RSUD Gatot Subroto, Majalah Farmasi dan Farmakologi, 25(1), 1-6.
[IDSA] Infectious Disease Society of America. 2019. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America, American Journal of Respiratory and Critical Care Medicine, 200(7), e45-e67.
Ilmi T, Yulia R, Herawati F. 2020. Evaluasi penggunaan antibiotik pada pasien pneumonia di Rumah Sakit Umum Daerah Tulungagung, Jurnal Inovasi Farmasi Indonesia (JAFI), 1(02).
Izadi M, Dadsetan B, Najafi Z, Jafari S, Mazaheri E, Dadras O, Hajar H, Seyed Ahmad A, Voltarelli F. 2018. Levofloxacin versus Ceftriaxone and Azithromycin combination in the treatment of community-acquired pneumonia in hospitalized patients, Recent Patents on Anti-Infective Drug Discovery, 13(3), 228–239.
Kemenkes RI. 2011. Pedoman Umum Penggunaan Antibiotik. Jakarta, Kementrian Kesehatan Republik Indonesia.
Kemenkes RI. 2012. Pedoman Pengendalian Penyakit Infeksi Saluran Pernapasan. Jakarta, Kementrian Kesehatan Republik Indonesia.
Kemenkes RI. 2013. Riset Kesehatan Dasar. Jakarta, Kementrian Kesehatan Republik Indonesia.
Kemenkes RI. 2015. Rencana Strategis Kementrian Kesehatan. Jakarta, Kementrian Kesehatan Republik Indonesia.
Kemenkes RI. 2018. Indonesia Health Profile 2017. Jakarta, Kementrian Kesehatan Republik Indonesia.
Kemenkes RI. 2021. Formularium Nasional. Jakarta, Kementrian Kesehatan Republik Indonesia.
Kusumawardani LA. 2019. Evaluation of antibiotic use in 2018 at the Kebayoran Baru Primary Health Care, Indonesia, using the anatomical therapeutic chemical/defined daily dose method. International Journal of Applied Pharmaceutics, 12(01).
[LKPP] Lembaga Kebijakan Pengadaan Barang/Jasa Pemerintah 2020, e-catalog obat 2020, https://e-katalog.lkpp.go.id/, diakses tanggal 25 Maret 2021.
Negara KS. 2014. Analisis implementasi kebijakan penggunaan antibiotika rasional untuk mencegah resistensi antibiotika di RSUP Sanglah Denpasar: Studi kasus infeksi Methicillin resistant Staphylococcus aureus, Jurnal Administrasi Kebijakan Kesehatan, 1(01).
PDPI. 2014. Pedoman Diagnosis dan Penatalaksanaan Pneumonia Komuniti di Indonesia. Jakarta, Perhimpunan Dokter Paru Indonesia.
Permenkes RI. 2015. Peraturan Menteri Kesehatan Republik Indonesia Nomor 8 Tahun 2015 Tentang Program Pengendalian Resistensi Antimikroba di Rumah Sakit. Jakarta, Kementrian Kesehatan RI.
Pinheiro L, Lien D, Claude L. 2011. X-Chromosome-Located microRNAs in immunity: Might they explain male/female differences? The X chromosome-genomic context may affect X-located MiRNAs and downstream signaling, thereby contributing to the enhanced immune response of females, Bio Essays, 33(11).
Raini m. 2016. Antibiotik golongan fluorokuinolon: Manfaat dan kerugian, Media Litbangkes, 26(03), 163-174.
Rizqi MH, Helmia H. 2014. Tinjauan imunologi pneumonia pada pasien geriatric, CDK-212, 41(1), 14-18
Trimble A. 2017. Pulmonary infection in the returned traveler, Pneumonia, 9(01).
WHO. 2014. World Pneumonia Day 2014: Pneumonia Fact Sheet, Geneva, World Health Organisation.
Yanuar W, Puspitasari I, Nuryastuti T. 2016. Evaluasi kesesuaian antibiotik definitif terhadap clinical outcome pada pasien anak dengan meningitis bakterial di Bangsal Rawat Inap Rumah Sakit Umum Pusat, Jurnal Manajemen dan Pelayanan Farmasi, 6(03).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
